Co-encapsulation of live cells with oxygen-generating particles

US9393272B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9393272-B2
Application numberUS-201214237214-A
CountryUS
Kind codeB2
Filing dateAug 9, 2012
Priority dateAug 9, 2011
Publication dateJul 19, 2016
Grant dateJul 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Microcapsules are described that comprise (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane surrounding said core; (c) live animal cells (e.g., pancreatic cells) in the core; and (d) oxygen-generating particles in said core, said oxygen-generating particles included in said microcapsules in an amount sufficient to lengthen the duration of viability of said animal cells in said microcapsules. Compositions comprising such microcapsules and uses thereof, such as in treating diabetes, are also described.

First claim

Opening claim text (preview).

That which is claimed is: 1. A microcapsule comprising: (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane layer surrounding said core; (c) live mammalian cells in said core, said cells are human pancreatic islet cells; (d) oxygen-generating particles in said core, said oxygen-generating particles included in said microcapsules in an amount sufficient to lengthen the duration of viability of said animal cells in said microcapsules; wherein said oxygen-generating particles comprise (i) magnesium peroxide, optionally in combination with a biodegradable polymer comprising alginate, and (ii) catalase; (e) an antioxidant, which is trolox; and (f) an auxiliary layer surrounding said semipermeable membrane layer, wherein said auxiliary layer comprises a biodegradable polymer comprised of sodium alginate, said biodegradable polymer containing an angiogenic agent in an amount effective to enhance the growth of blood vessels adjacent said microcapsule. 2. The microcapsule of claim 1 , wherein said angiogenic agent is vascular endothelial growth factor.

Assignees

Inventors

Classifications

  • containing heavy metals, e.g. hemin, hematin, melarsoprol · CPC title

  • Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title

  • the carrier being a carbohydrate · CPC title

  • Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title

  • A61K35/39Primary

    Pancreas; Islets of Langerhans (Langerhans cells of epidermis A61K35/36) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9393272B2 cover?
Microcapsules are described that comprise (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane surrounding said core; (c) live animal cells (e.g., pancreatic cells) in the core; and (d) oxygen-generating particles in said core, said oxygen-generating particles included in said microcapsules in an amount sufficient to lengthen the duration of viability of said animal cells in said…
Who is the assignee on this patent?
Opara Emmanuel C, Harrison Benjamin S, Univ Wake Forest Health Sciences
What technology area does this patent fall under?
Primary CPC classification A61K35/39. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).